Literature DB >> 8489121

Cyclosporine for thrombotic thrombocytopenic purpura.

H Kierdorf, N Maurin, B Heintz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8489121     DOI： 10.7326/0003-4819-118-12-199306150-00022

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Late response to cyclosporine in refractory thrombotic thrombocytopenic purpura.

Authors:  Annamaria Nosari; Patrizia Bernuzzi; Roberto Corneo; Ester Pungolino; Giuliana Muti; Valentina Rossi; Enrica Morra
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 2.  How I treat refractory thrombotic thrombocytopenic purpura.

Authors:  Farzana A Sayani; Charles S Abrams
Journal:  Blood       Date:  2015-03-17       Impact factor: 22.113

3.  High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.

Authors:  Tatsuya Adachi; Tadashi Matsushita; Ryoichi Ichihashi; Kanji Hirashima; Masafumi Ito; Akira Inukai; Toshiya Yokozawa; Tetsuya Nishida; Makoto Murata; Mutsuharu Hayashi; Akira Katsumi; Tetsuhito Kojima; Hidehiko Saito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 4.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 5.  Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature.

Authors:  Kaori Uchino; Kazuya Sakai; Saki Shinohara; Akifumi Matsuhisa; Yusuke Iida; Yuta Nakano; Saori Matsumura; Jo Kanasugi; Soichi Takasugi; Ayano Nakamura; Tomohiro Horio; Satsuki Murakami; Shohei Mizuno; Hidesuke Yamamoto; Ichiro Hanamura; Masanori Matsumoto; Akiyoshi Takami
Journal:  Int J Hematol       Date:  2022-03-10       Impact factor: 2.319

Review 6.  Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Ashley Hanlon; Ara Metjian
Journal:  Ther Adv Hematol       Date:  2020-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.